Actively Recruiting
Efficacy and Tolerability of a Hybrid Fractional Laser for the Treatment of Acne Scars in Patients With Skin of Color
Led by Albert Einstein College of Medicine · Updated on 2025-05-22
46
Participants Needed
1
Research Sites
150 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The investigators aim to investigate the efficacy and tolerability of a hybrid non-ablative/ablative laser for acne scarring in skin of color.
CONDITIONS
Official Title
Efficacy and Tolerability of a Hybrid Fractional Laser for the Treatment of Acne Scars in Patients With Skin of Color
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Healthy males and females 18 years or older at time of consent seeking treatment for acne scarring
- Must voluntarily sign an IRB approved informed consent form
- Diagnosis of acne scarring recorded within the past 6 months
- Able to read, understand, and provide written informed consent
- Healthy non-smokers
- Willing and able to follow the treatment protocol and follow-up schedule
- Agree not to have other procedures on the treatment areas during the study period
You will not qualify if you...
- Unable to consent to the study
- Acne scar treatments within 6 months before enrollment
- Active papulopustular or cystic acne within past 6 months
- History of keloidal scarring
- Surgical procedures in treatment area within past 12 months or major surgery within past 6 months
- Immunosuppression or immune deficiency disorders including AIDS/HIV
- Systemic chemotherapy within past 12 months
- Use of immunosuppressive medications or biologics within 6 months prior to and during study
- Use of Accutane or systemic retinoids within past 12 months
- Smoking or vaping within past 12 months
- History of photosensitivity or connective tissue disease
- History of hyperlipidemia, diabetes, hepatitis, or bleeding disorders
- History of major depressive or endocrine disorders including hypothyroidism, Hashimoto's thyroiditis, or hyperthyroidism
- Current pregnancy, breastfeeding, cancer, or epilepsy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
555 Taxter Road
Elmsford, New York, United States, 10523
Actively Recruiting
Research Team
A
Anika Jallorina, BS
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here